The growing problem around opioid addiction continues to receive coverage in the media, and it has become a topic of discussion on the campaign trail because candidates are being approached throughout the country by concerned families and citizens.
Marcia Taylor, President of Partnership For Drug Free Kids, provided testimony in January to a Senate Judiciary Committee on the need to increase funding for drug prevention and drug treatment. Proposed for consideration is the CARA Senate Bill which stands for Comprehensive Addiction and Recovery Act. CARA would allocate funding for drug treatment and prevention resources with a goal of getting more addicted individuals into treatment, and better educating both parents and teens on the dangers of recreational opioid use.
CARA would also address the need to distribute naloxone across the U.S. to aid in the fight to reduce deaths from opioid overdose. Local law enforcement would be trained on the administration of naloxone. Prescription drug monitoring programs would also receive increased support under CARA.
Methadone and Suboxone have become familiar interventions for anyone knowledgeable on opioid addiction issues. Most state-funded opioid treatment programs in the United States are currently full and have waiting lists of addicted people who are eager to participate in medication-assisted treatment.
In America, there has been a notable expansion in recent years of treatment programs who utilize methadone or suboxone to help patients. While many of these programs are private self-pay, Medicaid presently pays for methadone-based treatment approaches in a number of U.S. states. The number of private pay programs currently outnumber state-funded and Medicaid-funded programs by a substantial margin.
An article in the Huffington Post recently addressed President Obama’s public comments on expanding access to opioid treatment, particularly medication-assisted treatment (MAT) like methadone or buprenorphine (suboxone).
Many members of the treatment industry and recovery community do not have a realistic grasp on the role that medication-assisted treatment can play in recovery from severe opioid addiction. Historically, the recovery community has not regarded those utilizing methadone or suboxone as truly in recovery. They emphasize total abstinence, even from methadone, despite the fact that methadone and buprenorphine have restored individuals to normal functioning and even saved lives in many cases.
There was a time some years ago, in the 12 step community, when individuals were chastised for taking psychotropic medication for depression or other mental health disorders. This criticism came from a fundamental lack of knowledge about the biological basis for many mental health disorders. Similarly, medication-assisted treatment interventions have been the subject of misunderstanding and unwarranted rejection by those with limited education on varied treatment approaches.
As America’s opioid problem continues to grow, we need real solutions rooted in medical science and research. At this point in time, medication-assisted treatment has been in use long enough to clearly demonstrate its usefulness in facilitating personal recovery from addiction.
In 2015, we saw numerous local and national political figures rally around families that have been impacted by heroin overdoses and the heartbreaking loss of loved ones. Opioid addiction has finally come into focus within the mainstream media, and even current Presidential candidates have begun to address this as an important issue which commands attention and a solution.
Posted in Addiction Treatment, Buprenorphine, Heroin, Medication Assisted Treatment, Methadone, Methadone Benefits, Methadone Blog, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Treatment, Opiate Treatment, Relapse Prevention, Suboxone, Suboxone Physicians
Tagged medication-assisted treatment, obama
Drug and alcohol addiction are treatable illnesses. They can be successfully managed and “arrested” such that they do not continue to harm a person’s life or compromise their health. Just as with any progressive illness, a patient should commit to a course of treatment that has been proven to eradicate their illness or reduce its impact. Heart disease, cancer, diabetes, morbid obesity, alzheimer’s – all of these have established medical treatments which can increase a person’s chance of survival and/or quality of life.
Addiction is both a physiological and behavioral illness. With opioid addiction in particular, there is a strong biological/physical basis as well as a highly significant psychological component. When both of these are adequately addressed, a patient has a new opportunity to recover.
For most individuals with a severe opioid addiction, is critically important to receive physical relief from the discomfort of opioid withdrawal symptoms. But this must also happen in conjunction with behavioral health counseling. Counseling addresses the emotional & psychological factors that contributed to the development of addiction in the first place, and counseling teaches the skills necessary to remain drug free over the long-term and to hopefully avoid future relapses.
Many people find that if they neglect one of these two key areas, then they are more vulnerable to relapse and rapid deterioration. When opioid detox is not a viable option for a particular patient, methadone and suboxone are clearly the medications of choice for addressing opioid withdrawal. Counseling provides the other half of the equation. All methadone programs across the country (as well as all suboxone-approved physicians) are required to insure that their patients are receiving some level of addiction counseling.
The essential ingredient is this mix is patient commitment. Having a genuine desire for a drug free life is as important as anything else. Becoming ready for change is a process in itself and varies from person to person. It is true that many people find their way into recovery because of a recent crisis in which things get so bad they hit a new low, or bottom. This does not have to happen though.
Sometimes hitting “bottom” brings with it dire consequences. If you have been contemplating making a change, please remember that it is not too late. There are many advantages to acting today as opposed to waiting another day. Addiction loves procrastination. Recovery begins now with your commitment to doing something about your problem!
Posted in Addiction Recovery, Addiction Treatment, Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Success, Methadone Treatment, Opiate Treatment, Recovery, Recovery Support, Suboxone, Suboxone Doctors
Tagged recovery process, relapse prevention
Acadia Healthcare is a leading behavioral healthcare services provider headquartered out of Franklin, Tennessee. The company was established in 2005 and has experienced rapid growth as a result of strategic acquisitions and a sharp focus on the delivery of psychiatric and chemical dependency treatment services.
Acadia recently bought out CRC Health Group for a reported $1.2 billion in a well-publicized sale which closed in February 2015. The acquisition significantly expanded Acadia’s opioid addiction treatment capabilities adding approximately 82 methadone/suboxone facilities nationwide. The company is nicely positioned to serve tens of thousands of patients on a daily basis who are struggling with opioid addiction and other associated illnesses. Methadone and buprenorphine products are utilized in association with a variety of counseling approaches.
Just added to Methadone.US are five of Acadia’s opioid treatment clinics located in San Diego, Riverside, Baltimore, Portland, and Southern Indiana.
Acadia’s mission statement:
Acadia Healthcare’s mission is to create behavioral health centers where people receive care that enables them to regain hope in a supportive, caring environment.
The company presently has behavioral healthcare facilities in 37 U.S. states, the United Kingdom, and Puerto Rico. These include residential treatment centers, inpatient psychiatric hospitals, outpatient clinics, and therapeutic school-based programs.
Posted in Addiction Treatment, Buprenorphine, Drug Rehab Programs, Methadone, Methadone Clinics, Methadone Maintenance, Methadone Programs, Methadone Success, Methadone Treatment, Opiate Addiction, Opiate Treatment, Suboxone, Suboxone Clinics, Suboxone Doctors
Tagged Acadia, CRC Health
Right Path is an opioid treatment provider operating in the greater Hampton Roads area of eastern Virginia. The organization specializes in the use of burprenorphine (the critical ingredient in Suboxone that alleviates opioid withdrawal symptoms).
Right Path currently have outpatient services in Virginia Beach, Newport News, and Suffolk, but plan to soon offer a location convenient for residents and visitors along the Outer Banks.
Recognizing the importance of individualized treatment plans, Right Path tailor their services to the needs of the individual patient. While suboxone is beneficial in eliminating the pain of opioid withdrawal, addiction counseling is essential in helping patients to understand the addiction and recovery process. Right Path provide addiction counseling as a component of their overall treatment program.
Evening and weekend hours are offered, and most insurance is accepted. The Right Path website has a helpful page that outlines various questions and issues that you might cover with your Suboxone Doctor in your first appointment. Their website provides another highly informative page on Suboxone which answers many common questions about this increasingly popular medication. More information on Right Path’s locations and contact information can be obtained here:
Posted in Addiction Recovery, Buprenorphine, Drug Treatment, Methadone, Opiate Addiction, Opiate Treatment, Relapse Prevention, Suboxone, Suboxone Clinics, Suboxone Doctors, Suboxone Physicians
Tagged opioid treatment, Right Path, suboxone therapy